Carter, H.B.

cancer prostate prostate cancer screening study baseline antigen level value prostate-speci fic antigen biopsy urology baseline psa levels detection prostate-speci mortality european erspc testing trial randomized result population range psa levels european randomized study psa testing schroder baseline psa measurements round psa ranges prostate cancer detection baseline psa testing prostate cancer risk diagnosis erspc rotterdam speci group prostate cancer screening rotterdam prostate cancer diagnosis velocity baseline psa measurement disease psa values psa screening biopsied carter american control mortality results overdiagnosi baseline psa level number screen 4.0 ng /ml 3.0 ng /ml pca mortality catalona discussion evidence table schroder fh catalona wj predictor association analysis author sensitivity proportion review kranse r roobol mj rectal examination psa velocity biopsy indication family history prostate cancer deaths patient